Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
50.46
-1.43 (-2.76%)
At close: Mar 19, 2026, 4:00 PM EDT
50.60
+0.14 (0.28%)
After-hours: Mar 19, 2026, 7:38 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3.57 billion as of March 19, 2026. Its market cap has increased by 177.18% in one year.
Market Cap
3.57B
Enterprise Value
2.13B
1-Year Change
177.18%
Ranking
Category
Stock Price
$50.46
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.57B, an increase of 551.33%. That is a compound annual growth rate of 82.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 3.68B | -23.55% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.88B |
| Centessa Pharmaceuticals | 3.78B |
| Crinetics Pharmaceuticals | 3.73B |
| Corcept Therapeutics | 3.57B |
| ADMA Biologics | 3.52B |
| Dianthus Therapeutics | 3.51B |
| ACADIA Pharmaceuticals | 3.49B |
| NewAmsterdam Pharma Company | 3.42B |